New Humidification System Provides Improved Respiratory Support

By HospiMedica International staff writers
Posted on 15 Sep 2016
A high performance humidification system minimizes condensation and helps provide optimal breathing for patients.

The Fisher & Paykel Healthcare (F&P; Auckland, New Zealand) F&P 950 humidification system is designed to provide respiratory support across the care continuum of invasive, non-invasive, and Optiflow nasal high flow therapies, with a breathing circuit that remains closed and free of clinician intervention. The system consists of a heated humidifier base and an auto-fill chamber, with a touch screen intuitive user interface, integrated probes with novel sensing technologies, the breathing circuit itself, and a consumable sets.

Image: The F&P 950 humidification system (Photo courtesy of Fisher & Paykel Healthcare).

The breathing circuit incorporates patented Evaqua technology, which minimizes mobile condensation in the expiratory limb by allowing water vapor to diffuse through the tubing wall before it can condense into liquid water within the circuit limb or within the ventilator. The result is an easy-to-use system that delivers optimal humidity (37° C, 44mg/L) to the breathing circuits, which use spiral wire technology for consistent compliance and low resistance in order to inimize the work of breathing.

“The F&P 950 system is the result of many years’ development work and we are pleased to be introducing this revolutionary new product to the market,” said Lewis Gradon, managing director and CEO of F&P Healthcare. “It is an outstanding addition to our range of products and we expect to see positive uptake in hospitals around the world.”

Active respiratory gas humidification ensures that patients on mechanical ventilation are supplied with optimally conditioned gases, with a minimal water content of 33 mg/dm³ and a maximum respiratory gas temperature of about 42° C. Adding water to respiratory gas is intended to minimize pulmonary infections and lung tissue damage, which is particularly problematic in patient populations with highly sensitive respiratory tracts (such as asthmatics), or among those requiring ventilation for longer periods of time.

Related Links:
Fisher & Paykel Healthcare


Latest Critical Care News